QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing

by Ysios Capital

QIAGEN N.V. has announced it has entered into an agreement to acquire STAT-Dx, a privately-held company developing the next generation of multiplex diagnostics for one-step, fully integrated molecular...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Gordon Brothers Provides $100M Exit Faci...

by Gordon Brothers

Gordon Brothers, the global asset experts, has provided a $100 million...

Photos Stream